Click (NASDAQ:CLIK – Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.10 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of $3.79 million during the quarter.
Click Trading Down 7.0%
Shares of CLIK stock opened at $2.10 on Tuesday. Click has a 1 year low of $1.32 and a 1 year high of $34.20. The stock has a 50 day simple moving average of $2.69 and a 200 day simple moving average of $4.49.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Click in a research report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.
Click Company Profile
Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.
Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.
Featured Stories
- Five stocks we like better than Click
- AI Demand Fuels Strong Q1 Earnings for Constellation Energy
- Sony’s $4 Billion Bet on Rock & Roll Royalties
- Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
Receive News & Ratings for Click Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Click and related companies with MarketBeat.com's FREE daily email newsletter.
